Suppression of phagocytosis in patients on complement activating dialyzers

Kleinknecht, 1972, Uremic and non-uremic complications in acute renal failure: evaluation of early and frequent dialysis on prognosis, Kidney Int., 1, 190, 10.1038/ki.1972.26 Montgomerie, 1968, Renal failure and infection, Medicine, 47, 1, 10.1097/00005792-196801000-00001 Belcon, 1982, Tuberculosis in dialysis patients, Clin. Nephrol., 17, 14 Wey, 1989, Risk factors for hospital-acquired candidemia. A matched case-control study, Arch. Int. Med., 149, 2349, 10.1001/archinte.1989.00390100145030 Port, 1989, Neoplasms in dialysis patients: a population-based study, Am. J. Kidney Dis., 14, 119, 10.1016/S0272-6386(89)80187-8 Rautenberg, 1988, Influenza subtype-specific IgA, IgM and IgG responses in patients on hemodialysis after influenza vaccination, Infection, 16, 323, 10.1007/BF01644539 Köhler, 1984, Meyer zum Büsschenfelde KH. Active hepatitis B vaccination of dialysis patients and medical staff, Kidney Int., 25, 124, 10.1038/ki.1984.18 Correia, 1985, Why do patients with lupus nephritis die?, Br. Med. J. Clin. Res., 290, 126, 10.1136/bmj.290.6462.126 Lopez, 1989, Cellmediated immunity in healthy and uremic adults assessed by in vivo and in vitro techniques. Validation of delayed hypersensitivity skin testing, Allergol. Immunol. Madr., 17, 21 Goldblum, 1980, Host defences and immunologic alterations associated with chronic hemodialysis, Ann. Int. Med., 93, 597, 10.7326/0003-4819-93-4-597 Vanholder, 1989, Bioincompatibility: an overview, Int. J. Artif. Organs, 12, 356, 10.1177/039139888901200602 Hakim, 1984, Biocompatibility of dialysis membranes: effects of chronic complement activation, Kidney Int., 26, 194, 10.1038/ki.1984.155 Vanholder, 1987, Cuprophan reuse and intradialytic changes of lung diffus ion capacity and blood gasses, Kidney Int., 32, 117, 10.1038/ki.1987.180 Betz, 1988, Cupprammonium membranes stimulate interleukin 1 release and arachidonic acid metabolism in monocytes in the absence of complement, Kidney Int., 34, 67, 10.1038/ki.1988.146 Lambeth, 1988, Mini-reviews. Introduction: respiratory burst oxidase and its regulation, J. Bioenerg. Biomembranes, 20, 633, 10.1007/BF00762545 Ringoir, 1980, Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate, Clin. Nephrol., 13, 109 Vanholder, 1988, Cefodizime: a new cephalosporin with apparent immune-stimulating properties in chronic renal failure, Nephrol. Dial. Transplant, 3, 221 Vanholder, 1991, Phagocytosis in uremic and hemodialysis patients: a prospective and cross-sectional study, Kidney Int., 39, 320, 10.1038/ki.1991.40 Karnovsky, 1975, Biochemical aspects of the functions of polymorphonuclear and mononuclear leukocytes, 25 Forman, 1986, Oxidant production and bactericidal activity of phagocytes, Ann. Rev. Physiol., 48, 669, 10.1146/annurev.ph.48.030186.003321 Hakim, 1982, Hemodialysis-associated neutropenia and hypoxemia: the effect of dialyzer membrane materials, Nephron., 32, 32, 10.1159/000182728 Wiegmann, 1988, Dialysis leukopenia, hypoxemia, and anaphylatoxin formation: effect of membrane, bath, and citrate anticoagulation, Am. J. Kidney Dis., 11, 418, 10.1016/S0272-6386(88)80055-6 Ronco, 1990, Backfiltration in clinical dialysis: nature of the phenomenon, mechanisms and possible solutions, Int. J. Artif. Organs, 13, 11, 10.1177/039139889001300103